Market Overview:
The global high content imaging market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The market growth is attributed to the increasing demand for high content imaging in the life sciences and pharmaceutical industries for drug discovery and development. Additionally, the growing use of high content imaging in research institutes and academic institutions is also contributing to the growth of this market. On the basis of type, the global high content imaging market can be segmented into instruments, consumables, software, services, accessories, and others. The instruments segment accounted for a major share of this market in 2017 owing to its wide usage across various applications such as primary and secondary screening, target identification and validation studies toxicity studies compound profiling etc., In terms of revenue share too Instruments held more than 50% share in 2017 followed by Consumables which are projected witness highest CAGR during forecast period (2018-2030). On application front; Primary & Secondary Screening together held majority revenue share (~50%) followed by Target Identification & Validation Studies (~25%).
Product Definition:
High Content Imaging is the process of creating digital images of high-quality and high resolution. The images are used for scientific research, where minute details need to be observed.
Instruments:
Instruments are devices used to gather information. It can be a person or an animal. Instruments can be classified into two types: living and non-living. Non-living instruments include cameras, thermometers, pH meters and others which are further sub-classed into electronic sensors (temperature, pressure), mechanical instruments ( balances, scales) and imaging systems (x-ray scanners).
Consumables:
Consumables are the materials or devices that are used in a procedure or operation. They include products such as reagents, kits, and media. The consumables segment is expected to grow at a lucrative rate during the forecast period owing to their increasing use in diagnostic procedures and high-end imaging equipment.
Application Insights:
The primary screening segment dominated the global market in terms of revenue share in 2017. This is attributed to the high usage of HCI techniques for identifying and screening cancer biomarkers, which are present at low levels within tumor cells. The use of HCI equipment has also been significantly increasing for drug discovery and development programs as well as preclinical testing due to its ability to provide a comprehensive picture of tissue morphology, cell proliferation & survival, migration/invasion activities along with other related information such as protein expression or metabolite profiling.
High content imaging offers various advantages over conventional light microscopy including increased visibility of cellular details and allows visualization & analysis at molecular level by providing structural information about proteins or molecules under study. It also helps detect even the smallest abnormalities with greater accuracy owing to enhanced resolution (less than 200µm) provided by this technique coupled with advanced software packages that can be used for data processing.
Regional Analysis:
North America dominated the global market in 2017. The presence of major players, advanced healthcare infrastructure and high adoption rate for technologically advanced products are some of the factors contributing to its growth. Furthermore, increasing demand for diagnostic imaging across various applications is expected to drive the regional market over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising medical tourism and improving healthcare infrastructure in emerging countries such as India and China. In addition, growing target identification & validation application segment due to rapid technological advancements will support regional growth over the next eight years. Moreover, an increase in government initiatives aimed at developing new medicines from native plants or animals is expected fuel product innovation which will further propel High Content Imaging sales during this time frame (2016-2021).
Growth Factors:
- Increasing demand for high content imaging in the life sciences sector for drug discovery and development
- Rising demand from academic research institutes for high content screening to study complex biological processes
- Growing use of high content imaging in the diagnostics industry to detect early signs of diseases
- Proliferation of next-generation sequencing (NGS) platforms that require high content image analysis
- Increasing application of machine learning and artificial intelligence algorithms in high content image analysis
Scope Of The Report
Report Attributes
Report Details
Report Title
High Content Imaging Market Research Report
By Type
Instruments, Consumables, Software, Services, Accessories, High Content Imagin
By Application
Primary and Secondary Screening, Target Identification and Validation, Toxicity Studies, Compound Profiling, Others
By Companies
Albany Molecular Research, Cell Signaling Technology, Danaher Corp., GE Healthcare, Instrument Systems, Perkinelmer Inc., Thermo Fisher Scientific Inc., Becton Dickinson, Biotek Instruments Inc., Bio-Rad Laboratories Inc., Yokogawa Electric Corporation, Merck Millipore, High Content Imagin
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
243
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global High Content Imaging Market Report Segments:
The global High Content Imaging market is segmented on the basis of:
Types
Instruments, Consumables, Software, Services, Accessories, High Content Imagin
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Primary and Secondary Screening, Target Identification and Validation, Toxicity Studies, Compound Profiling, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Albany Molecular Research
- Cell Signaling Technology
- Danaher Corp.
- GE Healthcare
- Instrument Systems
- Perkinelmer Inc.
- Thermo Fisher Scientific Inc.
- Becton Dickinson
- Biotek Instruments Inc.
- Bio-Rad Laboratories Inc.
- Yokogawa Electric Corporation
- Merck Millipore
- High Content Imagin
Highlights of The High Content Imaging Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Instruments
- Consumables
- Software
- Services
- Accessories
- High Content Imagin
- By Application:
- Primary and Secondary Screening
- Target Identification and Validation
- Toxicity Studies
- Compound Profiling
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the High Content Imaging Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
High content imaging is a type of medical imaging that uses a higher resolution than traditional medical images. This allows doctors to see more detail and identify abnormalities more quickly.
Some of the key players operating in the high content imaging market are Albany Molecular Research, Cell Signaling Technology, Danaher Corp., GE Healthcare, Instrument Systems, Perkinelmer Inc., Thermo Fisher Scientific Inc., Becton Dickinson, Biotek Instruments Inc., Bio-Rad Laboratories Inc., Yokogawa Electric Corporation, Merck Millipore, High Content Imagin.
The high content imaging market is expected to register a CAGR of 10.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. High Content Imaging Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. High Content Imaging Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. High Content Imaging Market - Supply Chain
4.5. Global High Content Imaging Market Forecast
4.5.1. High Content Imaging Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. High Content Imaging Market Size (000 Units) and Y-o-Y Growth
4.5.3. High Content Imaging Market Absolute $ Opportunity
5. Global High Content Imaging Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. High Content Imaging Market Size and Volume Forecast by Type
5.3.1. Instruments
5.3.2. Consumables
5.3.3. Software
5.3.4. Services
5.3.5. Accessories
5.3.6. High Content Imagin
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global High Content Imaging Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. High Content Imaging Market Size and Volume Forecast by Application
6.3.1. Primary and Secondary Screening
6.3.2. Target Identification and Validation
6.3.3. Toxicity Studies
6.3.4. Compound Profiling
6.3.5. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global High Content Imaging Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. High Content Imaging Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global High Content Imaging Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. High Content Imaging Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global High Content Imaging Demand Share Forecast, 2019-2026
9. North America High Content Imaging Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America High Content Imaging Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America High Content Imaging Market Size and Volume Forecast by Application
9.4.1. Primary and Secondary Screening
9.4.2. Target Identification and Validation
9.4.3. Toxicity Studies
9.4.4. Compound Profiling
9.4.5. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America High Content Imaging Market Size and Volume Forecast by Type
9.7.1. Instruments
9.7.2. Consumables
9.7.3. Software
9.7.4. Services
9.7.5. Accessories
9.7.6. High Content Imagin
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America High Content Imaging Demand Share Forecast, 2019-2026
10. Latin America High Content Imaging Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America High Content Imaging Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America High Content Imaging Market Size and Volume Forecast by Application
10.4.1. Primary and Secondary Screening
10.4.2. Target Identification and Validation
10.4.3. Toxicity Studies
10.4.4. Compound Profiling
10.4.5. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America High Content Imaging Market Size and Volume Forecast by Type
10.7.1. Instruments
10.7.2. Consumables
10.7.3. Software
10.7.4. Services
10.7.5. Accessories
10.7.6. High Content Imagin
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America High Content Imaging Demand Share Forecast, 2019-2026
11. Europe High Content Imaging Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe High Content Imaging Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe High Content Imaging Market Size and Volume Forecast by Application
11.4.1. Primary and Secondary Screening
11.4.2. Target Identification and Validation
11.4.3. Toxicity Studies
11.4.4. Compound Profiling
11.4.5. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe High Content Imaging Market Size and Volume Forecast by Type
11.7.1. Instruments
11.7.2. Consumables
11.7.3. Software
11.7.4. Services
11.7.5. Accessories
11.7.6. High Content Imagin
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe High Content Imaging Demand Share, 2019-2026
12. Asia Pacific High Content Imaging Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific High Content Imaging Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific High Content Imaging Market Size and Volume Forecast by Application
12.4.1. Primary and Secondary Screening
12.4.2. Target Identification and Validation
12.4.3. Toxicity Studies
12.4.4. Compound Profiling
12.4.5. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific High Content Imaging Market Size and Volume Forecast by Type
12.7.1. Instruments
12.7.2. Consumables
12.7.3. Software
12.7.4. Services
12.7.5. Accessories
12.7.6. High Content Imagin
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific High Content Imaging Demand Share, 2019-2026
13. Middle East & Africa High Content Imaging Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa High Content Imaging Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa High Content Imaging Market Size and Volume Forecast by Application
13.4.1. Primary and Secondary Screening
13.4.2. Target Identification and Validation
13.4.3. Toxicity Studies
13.4.4. Compound Profiling
13.4.5. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa High Content Imaging Market Size and Volume Forecast by Type
13.7.1. Instruments
13.7.2. Consumables
13.7.3. Software
13.7.4. Services
13.7.5. Accessories
13.7.6. High Content Imagin
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa High Content Imaging Demand Share, 2019-2026
14. Competition Landscape
14.1. Global High Content Imaging Market: Market Share Analysis
14.2. High Content Imaging Distributors and Customers
14.3. High Content Imaging Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Albany Molecular Research
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Cell Signaling Technology
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Danaher Corp.
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. GE Healthcare
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Instrument Systems
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Perkinelmer Inc.
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Thermo Fisher Scientific Inc.
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Becton Dickinson
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Biotek Instruments Inc.
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Bio-Rad Laboratories Inc.
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Yokogawa Electric Corporation
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Merck Millipore
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. High Content Imagin
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
